Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish drugmaker in a more vulnerable ...

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish ...

Whether you’re training for your next race, hitting the trail, or simply need a new pair of running shoes, now is the perfect time to grab a pair of Brooks running shoes on sale.

I’ve been reviewing running shoes for a decade and one of the things I’ve learned over the years is there is no perfect shoe; all of them have different strengths and weaknesses that make them ...

As the weight loss treatment space reaches a new saturation point, Novo Nordisk, Eli Lilly and their closest—but still distant—competitors continue to vie for a greater share of the ever- expanding ...

Novo Nordisk announced this morning that it is ending its partnership with Hims & Hers, which allowed the telehealth provider to sell Novo's blockbuster weight-loss drug, Wegovy.

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of 10% to 15% of their body weight, roughly in line with results from a ...

Saucony is slashing the prices on some of its most popular running shoes for all abilities. Add to your cart before they sell out!